AG 013

Drug Profile

AG 013

Alternative Names: AG013; Lactococcus lactis expressing human trefoil factor 1; Lactococcus lactis secreting human trefoil factor 1; TFF1 - Intrexon; Trefoil factor 1 - Intrexon

Latest Information Update: 01 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ActoGeniX
  • Developer Intrexon Corporation; Oragenics Inc
  • Class Bacteria; Peptides
  • Mechanism of Action Mucoprotein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Stomatitis
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Stomatitis

Most Recent Events

  • 30 May 2018 Interim adverse events data from a phase II trial in Stomatitis released by Oragenics
  • 23 Mar 2018 Adverse events data from a phase Ib trial in Stomatitis released by Oragenics
  • 18 Jul 2017 Phase-II clinical trials in Stomatitis in USA (Topical) (NCT03234465)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top